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Conclusions: LMS PCI can be safely performed using radial arterial access. Operator
confidence to use radial access increases with period of time and experience.
Multivessel Disease
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Partial Revascularization Plus Medical Treatment Versus Medical Treatment Alone
In Patients With Multivessel Coronary Artery Disease Not Eligible For CABG
Mohamed A Sadaka, Mohamed loutfi, Mohamed Sobhy
Alexandria University, Alexandria, Egypt
Aim: The purpose of this study was to compare the impact of incomplete revascularization
(IR) plus OMT to OMT alone on 1 year clinical outcomes (death, hospitalization for
decompensated heart failure, acute coronary syndrome (ACS), angina class, ejection
fraction (EF) and repeated revascularization) in patients with multivessel coronary artery
disease (MVD) who were not eligible for coronary bypass graft surgery (CABG).
Methods: This is a prospective randomized study conducted on 50 selected patients with
chronic stable angina and without past history of revascularization; they have documented
MVD by standard coronary angiography and CABG were the only option of revascu-
larization but were refused by surgeon. All patients had non-viable myocardium
documented by viability studies were excluded from the study.
Patients were randomized 1:1 into two groups, group (I): 25 patients were subjected to
OMT alone and group (II): 25 patients were subjected to IR {PCI in one or two vessel
only with drug eluting stents (DES)} plus OMT. All patients were subjected to 1 year
follow up.
Results: The baseline patients’ characteristics were matched in the two studied groups.
Also, high syntax score (33) was almost found in majority of patients in both groups (23
patients in OMT group and in 24 patients in IR plus OMT group; p  1.000). All
patients were followed up for 1 year ; death occurred slightly more in IR plus OMT group
(16% versus 12%; p1.000), hospitalization for decompensated CHF occurred more in
the OMT group (28% versus 12%; p0.289), ACS occurred more in the OMT group
(32% versus 16%; p0.321) while freedom from angina occurred more in IR plus OMT
group (20% versus 4%; p0.189); however all these differences were not statistically
significant. In IR plus OMT group; TVR occurred in 16% of patients while non-TVR in
32% of patients. The OMT alone did not affect neither the level of angina class nor EF;
while the IR plus OMT markedly improved the decline in the level of angina class (p 
0.011), but it did not improve EF significantly (p 0.326).
Conclusion: In patients with MVD who were not eligible for CABG; IR plus OMT
was not superior to OMT alone in improving the 1year clinical outcomes except the
improvement in the level of angina class, which could be the adopted strategy to improve
the quality of life in such patients.
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Background: Chronic total occlusion (CTO) intervention is still challenging because of
the limited procedural success rate and higher recurrence. It is not clear whether the
presence of multivessel disease (MVD) will negatively impact on angiographic and clinical
outcomes following CTO intervention as compared with single vessel disease (SVD).
Methods: A total of 238 consecutive patients (pts) underwent CTO intervention were
divided into two groups according to the number of treated vessel (MVD with CTO:
n149 pts, SVD with CTO: n89 pts). Six-month angiographic and twelve-month
clinical outcomes were compared between the two groups.
Results: The baseline clinical characteristics were balanced between the two groups
except higher incidence of myocardial infarction (MI, 31.5 vs. 17.9 p0.021) and a lower
left ventricular ejection fraction (LVEF, 47.9712.1% vs. 52.759.3%, p0.001) in the
MVD group. The overall procedural success rate, procedural characteristics and procedure
related complications including perforation and dissection were not different between the
two groups. Angiographic outcomes at 6 months and major clinical outcomes up to 24
months were similar between the two groups except a trend toward higher incidence of
total death and major adverse cardiac events (MACE) in the MVD group (Table).
Conclusions: Once the CTO intervention was successful, the presence of MVD in
CTO patients did not negatively impact on 2-year major clinical outcomes.
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Background: In patients with ST-segment elevation myocardial infarction (STEMI)
and multivessel disease undergoing primary percutaneous coronary intervention (PCI),
staged non-culprit vessel PCI at a separate session is recommended. It is not known
whether performing staged PCI within the same hospitalization as the primary PCI is safe.
Methods: We analyzed 282 consecutive STEMI patients with multivessel disease who
underwent primary PCI followed by staged PCI of the non-culprit vessel. Patients were
categorized into staged PCI in the same hospitalization (n184) and staged PCI at a
separate hospitalization within 8 weeks of primary PCI (n98). In-hospital outcomes and
procedural complications after staged PCI were analyzed.
Results: Baseline characteristics, STEMI presentation and procedure characteristics
were similar in both groups. Contrast amount used was higher in the separate versus same
hospitalization group for both index (175 vs. 153ml, p0.011) and staged (144 vs. 120ml,
p0.004) PCI. More left main PCI occurred in the separate hospitalization group during
the staged PCI (3.9 vs. 0.3%, p0.008). Angiographic success of staged PCI was similar
in same versus separate hospitalization, with similar rates of vascular complications and
major bleeding, but a trend toward higher incidence of acute renal failure. Following
staged PCI, in-hospital major adverse cardiac events (3.3 vs. 1.0%, p0.43) and mortality
(2.7 vs. 0%, p0.17) were similar in both groups.
Conclusion: It is safe to perform staged PCI within the same hospitalization as primary
PCI, achieving similar procedural success and in-hospital outcomes as staged PCI at a
separate hospitalization. Higher contrast volume used during primary PCI and the
presence of left main lesion in non-culprit vessels may influence the decision to stage the
PCI at a separate hospitalization.
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